These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Peripheral arterial insufficiency and myocardial ischemia in ergotism. Report of a case and review of the literature]. Amaral LT; de Carvalho JG; Marks SG; Branco PP; Mulinari AS; Laffitte A Arq Bras Cardiol; 1984 Oct; 43(4):255-8. PubMed ID: 6536250 [No Abstract] [Full Text] [Related]
6. [Ergotamine; from headache to heartache]. Slob J; Burgersdijk C; Ruiter JH Ned Tijdschr Geneeskd; 1988 May; 132(20):927-30. PubMed ID: 3374687 [No Abstract] [Full Text] [Related]
7. [Peripheral circulatory disorder in the treatment of migraine with ergotamine]. Tüttenberg KH; Schuster CJ; Ungern-Sternberg AV; Kottmann UR; Schniepp KE; Limbourg P Med Welt; 1976 Jul; 27(29):1398-1400. PubMed ID: 957964 [No Abstract] [Full Text] [Related]
8. Ergotamine tartrate in migraine and the dangers of overdose. Wall MC Nurs Times; 1972 Dec; 68(50):1585. PubMed ID: 4640242 [No Abstract] [Full Text] [Related]
9. Ergotamine tartrate in the treatment of migraine. Wilkinson M; Wall WC Arch Neurobiol (Madr); 1974; 37 SUPPL():317-9. PubMed ID: 4462488 [No Abstract] [Full Text] [Related]
10. Ventricular fibrillation secondary to ergotamine in a healthy young woman. Velez Roa S; Preumont N; Mols P; Stoupel E; Renard M Acta Cardiol; 1999 Oct; 54(5):283-6. PubMed ID: 10596308 [TBL] [Abstract][Full Text] [Related]
11. Mitral and aortic valve disease associated with ergotamine therapy for migraine. Report of two cases and review of literature. Hauck AJ; Edwards WD; Danielson GK; Mullany CJ; Bresnahan DR Arch Pathol Lab Med; 1990 Jan; 114(1):62-4. PubMed ID: 2403780 [TBL] [Abstract][Full Text] [Related]
12. [A case of hyposphygmia caused by ergotamine in migraine]. Pulici S; Roncoroni G Minerva Med; 1975 Feb; 66(13):612-6. PubMed ID: 1113911 [No Abstract] [Full Text] [Related]
13. [After the numerous ergotamine preparations are on the way out. Migraine patients to change over to triptans]. MMW Fortschr Med; 2003 Oct; 145(42):63. PubMed ID: 14655450 [No Abstract] [Full Text] [Related]
14. [Benefits and risk of migraine drugs containing ergotamine]. Böhme HR; Dassow H; Ludewig R Z Arztl Fortbild (Jena); 1988; 82(24):1267-71. PubMed ID: 3068929 [No Abstract] [Full Text] [Related]
15. [Severe arterial spasms after the use of Ergotamine]. Hofstetter JR; Essinger A Schweiz Rundsch Med Prax; 1972 Feb; 61(6):180-2. PubMed ID: 5015803 [No Abstract] [Full Text] [Related]
16. Ergotamine as a possible cause of retroperitoneal fibrosis. Lepage-Savary D; Vallières A Clin Pharm; 1982; 1(2):179-80. PubMed ID: 7185517 [No Abstract] [Full Text] [Related]
17. A double-blind crossover trial of isometheptene mucate compound and ergotamine in migraine. Yuill GM; Swinburn WR; Liversedge LA Br J Clin Pract; 1972 Feb; 26(2):76-9. PubMed ID: 4552744 [No Abstract] [Full Text] [Related]
18. [Treatment of ergotism]. Schulz V Fortschr Med; 1984 Feb; 102(8):189-91. PubMed ID: 6745825 [TBL] [Abstract][Full Text] [Related]
19. [Ergotamine as a cause of arterial insufficiency]. Brinc L; Hjeltnes J Tidsskr Nor Laegeforen; 1974 Oct; 94(28):1906-7. PubMed ID: 4423231 [No Abstract] [Full Text] [Related]
20. Ergotamine: its use in the treatment of migraine and its complications. Saxena VK; De Deyn PP Acta Neurol (Napoli); 1992 Apr; 14(2):140-6. PubMed ID: 1329442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]